A detailed history of Cwm, LLC transactions in Simulations Plus, Inc. stock. As of the latest transaction made, Cwm, LLC holds 45 shares of SLP stock, worth $1,409. This represents 0.0% of its overall portfolio holdings.

Number of Shares
45
Previous 25 80.0%
Holding current value
$1,409
Previous $1,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 08, 2024

BUY
$30.46 - $46.86 $609 - $937
20 Added 80.0%
45 $1,000
Q2 2024

Jul 09, 2024

SELL
$38.46 - $50.95 $76 - $101
-2 Reduced 7.41%
25 $1,000
Q1 2024

Apr 05, 2024

BUY
$37.48 - $44.74 $74 - $89
2 Added 8.0%
27 $1,000
Q4 2023

Feb 01, 2024

BUY
$33.36 - $45.71 $300 - $411
9 Added 56.25%
25 $1,000
Q1 2023

Apr 28, 2023

SELL
$34.96 - $43.94 $1,852 - $2,328
-53 Reduced 76.81%
16 $1,000
Q4 2022

Feb 01, 2023

BUY
$36.55 - $51.15 $2,521 - $3,529
69 New
69 $3,000
Q4 2020

Jan 27, 2021

BUY
$53.26 - $77.18 $2,876 - $4,167
54 New
54 $4,000

Others Institutions Holding SLP

About Simulations Plus, Inc.


  • Ticker SLP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 20,297,700
  • Market Cap $636M
  • Description
  • Simulations Plus, Inc. develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. It operates through four segments: Simulations Plus, Cognigen, DILIsym, and Lixoft. The company offers GastroPlus, which sim...
More about SLP
Track This Portfolio

Track Cwm, LLC Portfolio

Follow Cwm, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cwm, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cwm, LLC with notifications on news.